Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 cases
- PMID: 31036039
- PMCID: PMC6489191
- DOI: 10.1186/s13052-019-0641-y
Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 cases
Abstract
Objective: To report the clinical features of patients with systemic lupus erythematosus (SLE) associated with thrombotic thrombocytopenic purpura (TTP). Their diagnosis, treatment, and prognosis were also discussed.
Methods: A total of 25 TTP-SLE pediatric patients were included in this study. Their clinical symptoms, laboratory findings, disease activity, and renal biopsy were retrospectively reviewed.
Results: The median age of the patient cohort was 14 years old. Nine patients were first diagnosed with SLE, followed by the diagnosis of TTP-SLE, whereas 15 patients were diagnosed with TTP and SLE concurrently. All the 25 TTP-SLE patients had decreased platelet count and microangiopathic hemolytic anemia. Fever, rash, edema and neurological symptoms were the main clinical symptoms. Fragmentation of erythrocytes on blood smear and increased LDH were found in all patients. Nineteen patients (76%) had impaired renal function. Renal biopsy showed that most of the patients had lupus nephritis class IV (20%) and TMA (20%). 13 patients (52%) were treated with glucocorticoids in combination with immunosuppressive agent, and 10 patients (40%) were treated with plasma exchange combined with glucocorticoids plus immunosuppressive agent. One patient died due to lung infection; others had disease remission. Fifteen patients had follow-up regularly, and their conditions were stable.
Conclusion: Patients with TTP-SLE often had moderate to severe lupus disease activity. Testing of LDH level and blood smear should be performed when kidney and neurological symptoms arise in children with SLE. The use of combination therapy, glucocorticoids plus immunosuppressive agent, provided satisfactory clinical outcome. Patients with refractory TTP-SLE will also need plasma exchange therapy.
Keywords: Clinical features; Prognosis; Systemic lupus erythematosus; Thrombotic thrombocytopenic purpura.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
There is no competing interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.Am J Case Rep. 2016 Oct 25;17:782-787. doi: 10.12659/ajcr.898955. Am J Case Rep. 2016. PMID: 27777394 Free PMC article. Review.
-
Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.Lupus. 2020 Dec;29(14):1961-1967. doi: 10.1177/0961203320953473. Epub 2020 Aug 24. Lupus. 2020. PMID: 32838618
-
[The clinical analysis of 14 cases of systemic lupus erythematosus complicated by thrombotic thrombocytopenic purpura].Zhonghua Nei Ke Za Zhi. 2013 May;52(5):383-6. Zhonghua Nei Ke Za Zhi. 2013. PMID: 23945302 Chinese.
-
Thrombotic thrombocytopenic purpura and systemic lupus erythematosus - distinct entities or overlapping syndromes?Transfus Apher Sci. 2006 Jun;34(3):263-6. doi: 10.1016/j.transci.2006.02.001. Epub 2006 Jun 23. Transfus Apher Sci. 2006. PMID: 16798092
-
Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review.Clin Rheumatol. 2003 Oct;22(4-5):355-8. doi: 10.1007/s10067-003-0742-1. Clin Rheumatol. 2003. PMID: 14579168 Review.
Cited by
-
Dengue Infection Triggering Concurrent Thrombotic Thrombocytopenic Purpura in a Case of Chronic Idiopathic Thrombocytopenic Purpura.Cureus. 2023 Aug 18;15(8):e43684. doi: 10.7759/cureus.43684. eCollection 2023 Aug. Cureus. 2023. PMID: 37724240 Free PMC article.
-
Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient.CEN Case Rep. 2020 Nov;9(4):301-307. doi: 10.1007/s13730-020-00475-9. Epub 2020 Apr 18. CEN Case Rep. 2020. PMID: 32304042 Free PMC article.
-
Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report.J Int Med Res. 2022 Mar;50(3):3000605221085127. doi: 10.1177/03000605221085127. J Int Med Res. 2022. PMID: 35352601 Free PMC article.
-
Case Report: Systemic lupus erythematous associated with thrombotic thrombocytopenic purpura, a diagnostic challenge.F1000Res. 2022 May 25;10:552. doi: 10.12688/f1000research.51295.2. eCollection 2021. F1000Res. 2022. PMID: 37457554 Free PMC article.
-
The features and risk factors of thrombotic thrombocytopenic purpura in systemic lupus erythematosus.Orphanet J Rare Dis. 2025 Apr 28;20(1):203. doi: 10.1186/s13023-025-03741-0. Orphanet J Rare Dis. 2025. PMID: 40296018 Free PMC article.
References
-
- Musio F, Bohen EM, Yuan CM, Welch PG. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin arthritis rheum. Case Reports Review. 1998;28(1):1–19. - PubMed
-
- Letchumanan P, Ng HJ, Lee LH, Thumboo J. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus. Rheumatology (Oxford) Comparative Study. 2009;48(4):399–403. - PubMed
-
- Schapkaitz E, Schickerling TM. The diagnostic challenge of acquired thrombotic thrombocytopenic Purpura in children: case report and review of the literature. Lab Med. 2018;49(3):268–271. - PubMed
MeSH terms
Substances
Grants and funding
- 201402012/Public Welfare Scientific Research Project of China
- 2016ZX310182-1/CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses to HW
- 2016-I2M-1-008/Center for Innovative Medicine, Johns Hopkins University
- 2016-2-40114/The Capital Health Research and Development of Special
LinkOut - more resources
Full Text Sources
Medical